La revue ACVD d'octobre est parue.
Scientific editorial
- How should we manage left atrial thrombosis?
Clinical research
- A novel personalized approach to cardiovascular prevention: The VIVOPTIM programme
- Reproducibility of reading echocardiographic parameters to assess severity of mitral regurgitation. Insights from a French multicentre study
- Red blood cell distribution width in addition to N-terminal prohormone of B-type natriuretic peptide concentration improves assessment of risk of cardiovascular events in adult patients with congenital heart disease
- Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome
- Prognostic importance of Kidney, Heart and Interstitial lung diseases (KHI triad) in PH: A machine learning study
Reviews
- Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and atrial thrombosis: An appraisal of current evidence-
Review in translational cardiovascular medicine
- Colchicine and myocardial infarction: A review
Expert consensus
- Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology